ASTRAZENECA PLC (AZNCF)
Clinical trial NCT03899337 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-05-31 → 2028-07-31 3. primary completion date: 2025-10-31 → 2028-06-30 4. enrollment: 105 → 72 participants 5. enrollment type: ESTIMATED → ACTUAL 6. collaborators added: AstraZeneca 7. collaborators removed: Acerta Pharma, LLC
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical